Securities Class Action Filed Against FXCM Inc.

Violations of federal securities laws as a result of a series of materially false statements. The lawsuit alleges that, during the Class Period, Defendants made false and/or misleading statements that: (1) FXCM’s agency model of FX trading was extremely low-risk; (2) the volatility in FX markets was uniformly good for FXCM’s business; (3) expressed confidence in the capability of FXCM’s proprietary technological platform; and (4) FXCM maintained sufficient regulatory capital reserves for unforeseen scenarios. According to the Complaint, FXCM announced on January 16, 2015 that it been given a loan from Leucadia National Corp. for $300 million for the purpose of staving off the regulatory default and possible bankruptcy facing the Company. Trading of FXCM’s stock was suspended upon release of this news and, once the stock resumed trading, shares of FXCM fell $11.03 per share to close at $1.60 per share on January 20, 2015. Filed in S.D.N.Y.

Lead Plaintiff Deadline: The deadline to file for lead plaintiff in this action is 7/7/2015.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah, LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.

A Message to Our Clients About Coronavirus COVID-19:

A Message to Our Clients About Coronavirus COVID-19

At Shepherd, Finkelman, Miller & Shah, LLP, we view the safety and well-being of our clients, staff and business partners as our highest priority.

The situation regarding the COVID-19 virus is continually changing, and we are following all recommended guidelines to stay healthy. As a result, our lawyers and staff are working remotely in accordance with the CDC's recommendations. We continue to work for all of our clients and are happy to arrange for phone or video consultations. We are also able to exchange documents via secure drives or email.

Please contact us online or call 866-540-5505 with any questions.

Thank you and take care.